Judith Parsells Kelly, M.S.

Judy KellyEpidemiologist
Slone Epidemiology Center

jlpkelly@bu.edu

Education:

B.S.N., 1974, University of Massachusetts, Amherst
M.S., 1981, University of Massachusetts, Amherst

Research Interests:

Ms. Kelly has a longstanding interest in the epidemiologic study of rare, drug-induced disease. She has been involved in case-control studies investigating the etiology of agranulocytosis, aplastic anemia, and thrombocytopenia purpura; Stevens-Johnson syndrome and toxic epidermal necrosis; and anaphylaxis. A particular interest is in the area of analgesic-induced illness, including gastrointestinal bleeding and end-stage renal disease.

From 1998 through 2008, Ms. Kelly’s research efforts were focused on a nationwide, random digit dial telephone survey of medication use. Since then, she has been involved in a study of a possible protective role against renal calculi of a colonic bacterium, Oxalobacter formigenes, and a study of neurocognitive and psychosocial outcomes in children with hemifacial microsomia. Her current activities include participation in several studies of acetaminophen use in the U.S. adult population, a study to determine whether subjects can be recruited through a physicians’ social network, and a postmarketing surveillance study for a newly approved blood product.

Selected Publications

  • Kaufman DW, Kelly JP, Rohay JM, Malone MK, Weinstein RB, Shiffman S. Prevalence and correlates of exceeding the labeled maximum dose of acetaminophen among adults in a U.S.-based internet survey. Pharmacoepidemiol Drug Saf 2012;21:1280-88. doi: 10.1002/pds.3350.
  • Kelly JP, Kaufman DW, Dunant A, Mockenhaupt M, Roujeau JC. Response to “Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole” [letter to the editor]. J Am Acad Dermatol 2011;64(6):1193-4.
  • Kelly JP, Curhan GC, Cave DR, Anderson TE, Kaufman DW. Factors related to colonization with Oxalobacter formigenes in U.S. adults. J Endourol 2011;25(4):673-9.
  • Dufton L, Speltz ML, Kelly JP, Leroux B, Collett BR, Werler MM. Psychosocial outcomes in children with hemifacial microsomia. J Pediatr Psychol 2011;36(7):794-805.
  • Collett BR, Speltz ML, Cloonan YK, Leroux BG, Kelly JP, Werler MM. Neurodevelopmental outcomes in children with hemifacial microsomia. Arch Pediatr Adolesc Med 2011;165(2):134-40.
  • Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Vitamin, fluoride, and iron use among US children younger than 12 years of age: results from the Slone Survey 1998-2007. J Am Diet Assoc 2011;111(2):285-9.
  • Coogan PF, Kelly JP, Strom BL, Rosenberg L. Statin and NSAID use and prostate cancer risk. Pharmacoepidemiol Drug Saf 2010;19:752-5.
  • Hall SA, Chiu GR, Kaufman DW, Kelly JP, Link CL, Kupelian V, McKinlay JB. General exposures to prescription medications by race/ethnicity in a population-based sample: results from the Boston Area Community Health Survey. Pharmacoepidemiol Drug Saf 2010;19(4):384-92.
  • Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Medication use among children < 12 years of age in the United States: results from the Slone Survey, 1998-2007. Pediatrics 2009;124(2):446-54.
  • Willy M, Kelly JP, Nourjah P, Kaufman DK, Budnitz D, Staffa J. Emergency department visits attributed to selected analgesics, United States, 2004-2005. Pharmacoepidemiol Drug Saf 2009;18(3):188-95.
  • Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Cough and cold medication use by U.S. children, 1999-2006: results from the Slone Survey. Pediatrics 2008;122(2):e323-9.
  • Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 2008;19(6):1197-203.
  • Kelly JP, Cook SF, Kaufman DW, Anderson TE, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the U.S. adult population. Pain 2008;138(3):507-13.
  • Kelly JP, Coogan P, Strom BL, Rosenberg L. Lung cancer and regular use of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs. Pharmacoepidemiol Drug Saf 2008;17:322-7.
  • Henrich WL, Clark RL, Kelly JP, Buckalew VM, Fenves A, Finn WF, Shapiro JI, Kimmel PL, Eggers P, Agodoa LE, Porter GA, Shapiro S, Toto R, Anderson T, Cupples LA, Kaufman DW. Non-contrast-enhanced computerized tomography and analgesic-related kidney disease: report of the National Analgesic Nephropathy Study. J Am Soc Nephrol 2006;17:1472-80.
  • Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Mitchell AA. Use of herbal/natural supplements according to racial/ethnic group. J Altern Complement Med 2006;12(6):555-61.
  • Kelly JP, Kaufman DW, Rosenberg L, Kelley K, Cooper SG, Mitchell AA. Use of postmenopausal hormone therapy since the Women’s Health Initiative findings. Pharmacoepidemiol Drug Saf 2005;14(12):837-42.
  • Kelly JP, Kaufman DW, Kelley KE, Rosenberg L, Anderson TE, Mitchell AA. Recent trends in use of herbal and other natural products. Arch Intern Med 2005;165:281-6.
  • Shapiro S, Rosenberg L, Hoffman M, Kelly JP, Cooper DD, Carrara H, Williamson AL, Denny LE, du Toit G, Allan BR, Stander IA. Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives (South Africa). Cancer Causes Control 2003;14:485-95.
  • Kaufman DW, Kelly JP, and the International Collaborative Study of Severe Anaphylaxis. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf 2003;12:195-202.
  • Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. J Am Med Assoc 2002;287:337-44.
  • Kaufman DW, Kelly JP, and the International Case-Control Study of Severe Cutaneous Adverse Reactions. Acetylsalicylic acid and other salicylates in relation to Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Clin Pharmacol 2001;51:174-6.
  • Kelly JP, Rosenberg L, Palmer JR, Rao RS, Strom BL, Stolley PD, Zauber AG, Shapiro S. Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines. Am J Epidemiol 1999;150:861-8.
  • Kelly JP, Laszlo A, Kaufman DW, Sundstrom A, Shapiro S. Major upper gastrointestinal bleeding and the use of calcium channel blockers [research letter]. Lancet 1999;353:559.
  • László A, Kelly JP, Kaufman DW, Sheehan JE, Rétsági G, Wilholm BE, Koff RS, Sundström A, Shapiro S. Clinical aspects of upper gastrointestinal bleeding associated with the use of nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 1998;93:721-5.
  • Kaufman DW, Kelly JP, Anderson T, Harmon DC, Shapiro S. Evaluation of case reports of aplastic anemia among patients treated with felbamate. Epilepsia 1997;38:1265-9.
  • Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996;348:1413-6.
  • Roujeau J-C, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, Mockenhaupt M, Paoletti C, Shapiro S, Shear N, Schöpf E, Kaufman DW. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
  • Kelly JP, Auquier A, Rzany B, Naldi L, Bastuji-Garin S, Correia O, Shapiro S, Kaufman DW. An international collaborative case-control study of severe cutaneous adverse reactions (SCAR): design and methods. J Clin Epidemiol 1995;48:1099-108.
  • Kelly JP, Kaufman DW, Koff RS, Laszlo A, Wiholm BE, Shapiro S. Alcohol consumption and the risk of major upper gastrointestinal bleeding. Am J Gastroenterol 1995;90:1058-64.
  • Kaufman DW, Kelly JP, Johannes CB, Sandler A, Harmon D, Stolley PD, Shapiro S. Acute thrombocytopenic purpura in relation to the use of drugs. Blood 1993;82:2714-8.
  • Kaufman DW, Kelly JP, Sheehan JE, Laszlo A, Wilhom BE, Alfredsson L, Koff R, Shapiro S. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993;53:485-94.
  • Kelly JP, Kaufman DW, Shapiro S. Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: the International Agranulocytosis and Aplastic Anemia Study. Clin Pharmacol Ther 1991;49:330-41.
  • Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis and aplastic anemia: the International Agranulocytosis and Aplastic Anemia Study. New York: Oxford University Press, 1991.
  • Kelly JP, Rosenberg L, Kaufman DW, Shapiro S. Reliability of personal interview data in a hospital-based case-control study. Am J Epidemiol 1990;131:79-90.